To confirm the impact on prostate cancer stem cells, the intensity of cancer stem cell marker CD44 in VCaP, LNCaP, PC-3 and DU-145 prostate cancer cells was studied in response salinomycin exposure (1 μM) using fluorescence-activated cell-sorting analysis. Here, CD44 is linked to prostate carcinoma.